Evidence map›Paper›PMID 33479031›Full record

ArticleTobacco control2022

Association of device type, flavours and vaping behaviour with tobacco product transitions among adult electronic cigarette users in the USA.

Alyssa F Harlow, Jessica L Fetterman, Craig S Ross, Rose Marie Robertson, Aruni Bhatnagar, Emelia J Benjamin, Andrew C Stokes

Open access · greenAbstract read
In one paragraph

Article in Tobacco control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Evaluation of Dual Use: Real Time Reductions in Combustible Cigarette Smoking During Co-Occurring Use of E-Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. The Impact of Current Tobacco Product Use Definitions on Estimates of Transitions Between Cigarette and ENDS Use.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Alyssa F HarlowDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA afharlow@bu.edu.ORCID 0000-0001-6744-6988
Jessica L FettermanDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Craig S RossDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
Rose Marie RobertsonTobacco Regulation and Addiction Center, American Heart Association, Dallas, Texas, USA.
Aruni BhatnagarDepartment of Medicine, University of Louisville, Louisville, Kentucky, USA.
Emelia J BenjaminDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
Andrew C StokesDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0002-8502-3636
Boston University · USAmerican Heart Association · USUniversity of Louisville · US

Funding

ConProject-006U54HL120163 · NHLBI · AMERICAN HEART ASSOCIATION · PI BHATNAGAR, ARUNI, ROBERTSON, ROSE MARIE · 2018 to 2022
$18.8M
Novel Methods for Evaluating the Association of Electronic Cigarette Use with Cardiovascular HealthK01HL154130 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI STOKES, ANDREW · 2020 to 2024
$904k
Relations of Mitochondrial Genetic Variation and Function with Atrial FibrillationK01HL143142 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FETTERMAN, JESSICA L · 2019 to 2023
$757k
NHLBI NIH HHS K01 HL143142NHLBI NIH HHS K01 HL154130NHLBI NIH HHS U54 HL120163
6 · The paper itself

Abstract

backgroundFew studies assess whether electronic cigarette (e-cigarette) device characteristics or flavours impact longitudinal patterns of cigarette and e-cigarette use.

designWe examined data from waves 2-4 of the Population Assessment of Tobacco and Health Study (2014-2018). Among adult (≥18 years) current e-cigarette users at wave 2 who were current smokers (dual users; n=1759) and former smokers (exclusive e-cigarette users; n=470), we classified participants into four use patterns at wave 3 (~12 months later) and wave 4 (~24 months later): (1) dual use of e-cigarettes and cigarettes; (2) exclusive cigarette smoking; (3) exclusive e-cigarette use; (4) non-use of both products. We used multinomial logistic regression to assess correlates of changing use patterns at 24 months, relative to no change, adjusting for sociodemographic factors.

resultsAt 24 months, 26.5% of baseline exclusive e-cigarette users, and 9% of baseline dual users, abstained from both vaping and smoking. Participants who vaped non-tobacco flavours (vs tobacco flavours), and used refillable tank or modifiable devices (vs disposable, cartridges and other devices) were less likely to transition to non-use of both products and to exclusive cigarette smoking. Baseline daily vaping (vs non-daily) was positively associated with exclusive e-cigarette use at 24 months for baseline daily cigarette smokers, but negatively associated with exclusive e-cigarette use and non-use of both products at 24 months for baseline non-daily smokers.

conclusionsNon-tobacco flavours, daily vaping and modifiable e-cigarette devices may help some smokers abstain from cigarette smoking via transitioning to exclusive e-cigarette use, but are also associated with ongoing exclusive e-cigarette use.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsVapingAdultFlavoring AgentsHumansSmokersUnited StatesFlavoring Agentscessationelectronic nicotine delivery devicesnon-cigarette tobacco products

Identifiers

PMID33479031
PMCPMC8292448
OpenAlexW3126096689

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.